Quantcast
CYCC

Cyclacel Pharmaceuticals, Inc. Competitors

$0.48
*  
0.0229
5.01%
Get CYCC Alerts
*Delayed - data as of Aug. 20, 2019  -  Find a broker to begin trading CYCC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CYCC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Cyclacel Pharmaceuticals, Inc.

CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Atreca, Inc.
BCEL: NASDAQ-GS
$ 20.59 2.99 ▲ 183,291 $ 20.8999
$ 16.925
$ 20
$ 10.29
NE 470,482
G1 Therapeutics, Inc.
GTHX: NASDAQ-GS
$ 38.84 1.97 ▲ 201,901 $ 39.20
$ 36.17
$ 69.57
$ 13.87
NE 1,455,218
Eidos Therapeutics, Inc.
EIDX: NASDAQ-GS
$ 44.855 1.09 ▲ 178,857 $ 45
$ 43.35
$ 45
$ 8.89
NE 1,651,920
Zealand Pharma A/S
ZEAL: NASDAQ-GS
$ 21.81 1.02 ▲ 1,580 $ 21.81
$ 21.81
$ 23.55
$ 11.51
7.79 693,885
Ionis Pharmaceuticals, Inc.
IONS: NASDAQ-GS
$ 70.96 0.96 ▲ 871,651 $ 71.58
$ 69.65
$ 86.582
$ 43.27
25.43 9,957,320
Synthorx, Inc.
THOR: NASDAQ-GS
$ 18.09 0.95 ▲ 77,447 $ 18.11
$ 16.34
$ 23.5259
$ 11
NE 583,692
PhaseBio Pharmaceuticals, Inc.
PHAS: NASDAQ-GM
$ 8.41 0.93 ▲ 81,266 $ 8.49
$ 7.40
$ 16.65
$ 2.55
NE 240,753
Zymeworks Inc.
ZYME: NYSE
$ 26.15 0.90 ▲ 131,653 $ 26.22
$ 25.06
$ 27.19
$ 10.72
NE 1,026,649
Stoke Therapeutics, Inc.
STOK: NASDAQ-GS
$ 32.495 0.90 ▲ 94,877 $ 33
$ 30.4917
$ 31.97
$ 22.01
NE 983,624
Jazz Pharmaceuticals plc
JAZZ: NASDAQ-GS
$ 136.56 0.81 ▲ 296,800 $ 138.45
$ 135.635
$ 176.725
$ 113.5182
12.32 7,737,626
Protagonist Therapeutics, Inc.
PTGX: NASDAQ-GM
$ 11.80 0.76 ▲ 165,499 $ 11.84
$ 11.12
$ 14.36
$ 5.4927
NE 276,073
Odonate Therapeutics, Inc.
ODT: NASDAQ-GS
$ 34.42 0.74 ▲ 50,632 $ 34.76
$ 31.53
$ 43.75
$ 11.54
NE 1,107,877
Phibro Animal Health Corporation
PAHC: NASDAQ-GM
$ 32.65 0.73 ▲ 275,128 $ 33.97
$ 31.92
$ 54.6202
$ 27.315
19.43 662,403
Milestone Pharmaceuticals Inc.
MIST: NASDAQ-GS
$ 18.52 0.72 ▲ 3,529 $ 19.3246
$ 17.97
$ 27.95
$ 15.09
NE 453,573
NuCana plc
NCNA: NASDAQ-GS
$ 8 0.68 ▲ 844,496 $ 9.15
$ 4.01
$ 30.10
$ 6.80
NE 257,808
BridgeBio Pharma, Inc.
BBIO: NASDAQ-GS
$ 28.72 0.67 ▲ 155,851 $ 29.11
$ 27.85
$ 32.812
$ 24.0556
NE 3,302,800
Sage Therapeutics, Inc.
SAGE: NASDAQ-GM
$ 165 0.65 ▲ 202,182 $ 166.5707
$ 162.41
$ 193.56
$ 79.88
NE 8,439,420
Zynerba Pharmaceuticals, Inc.
ZYNE: NASDAQ-GM
$ 11.92 0.62 ▲ 706,694 $ 12.04
$ 11.35
$ 16.47
$ 2.75
NE 251,214
Puma Biotechnology Inc
PBYI: NASDAQ-GS
$ 10.77 0.57 ▲ 1,201,666 $ 10.845
$ 10.07
$ 50.75
$ 8.45
NE 415,851
VIVUS, Inc.
VVUS: NASDAQ-GS
$ 3.96 0.56 ▲ 3,405,799 $ 4.40
$ 3.71
$ 6.41
$ 2.15
NE 42,146
Fulcrum Therapeutics, Inc.
FULC: NASDAQ-GM
$ 11.51 0.55 ▲ 99,359 $ 11.81
$ 10.15
$ 15.94
$ 8.19
NE 268,643
Mereo BioPharma Group plc
MREO: NASDAQ-GM
$ 4.093 0.54 ▲ 88,958 $ 4.20
$ 3.80
$ 8.48
$ 2.18
NE 77,755
Karuna Therapeutics, Inc.
KRTX: NASDAQ-GM
$ 21.75 0.52 ▲ 54,007 $ 21.87
$ 20.85
$ 29
$ 16.95
NE 509,233
Apellis Pharmaceuticals, Inc.
APLS: NASDAQ-GS
$ 29.40 0.50 ▲ 223,315 $ 29.74
$ 29.04
$ 29.89
$ 11.45
NE 1,859,021
Endo International plc
ENDP: NASDAQ-GS
$ 3.02 0.47 ▲ 18,905,218 $ 3.40
$ 2.72
$ 18.50
$ 2.14
NE 683,070